Sui-ling Y. Sin - Publications

High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter.

Journal: BMC gastroenterology

Published: March 25, 2023

Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.

Journal: Hepatology (Baltimore, Md.)

Published: April 30, 2020

Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: April 23, 2020

Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B.

Journal: Hepatology (Baltimore, Md.)

Published: August 08, 2019

An expressive-arts-based life-death education program for the elderly: A qualitative study.

Journal: Death studies

Published: December 08, 2018

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.

Journal: Transplantation

Published: July 22, 2017

Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years.

Journal: Hepatology (Baltimore, Md.)

Published: January 08, 2017

Clinical factors affecting rejection rates in liver transplantation.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: August 11, 2015

Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 17, 2015